Author

Michael A. Fournel

Observed names: M A Fournel, M Fournel, M. A. Fournel, M. FOURNEL, M. Fournel, M.A. Fournel, MICHAEL A. FOURNEL, Michael A Fournel, Michael Fournel

Observed institutions: United States Department of Veterans Affairs, Bayer (United States), Veterans Health Administration, Oklahoma Medical Research Foundation, Bayer (Japan), Institute of Medical Science, The University of Tokyo, University of Oklahoma Health Sciences Center, The University of Tokyo, University of Oklahoma

OpenAlex ID: A5013262267

Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment

2010 · Baisong Mei, Clark Pan, et al. · Blood · 235

PDF

Lethal Staphylococcus Aureus-induced Shock in Primates

1992 · Lerner B. Hinshaw, Thomas E. Emerson, et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 140

Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein

2000 · Douglas C. Lee, Christopher J. Stenland, et al. · Journal of Virological Methods · 133

Comparative study of the sugar chains of factor VIII purified from human plasma and from the culture media of recombinant baby hamster kidney cells.

1992 · T Hironaka, K Furukawa, et al. · Journal of Biological Chemistry · 131

Monoclonal antibody to tumor necrosis factor--alpha prevents lethal endotoxin sepsis in adult rhesus monkeys.

1992 · V B Fiedler, I Loof, et al. · PubMed · 113

A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins

2001 · Douglas C. Lee, Christopher J. Stenland, et al. · Transfusion · 112

PDF

Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia

1989 · Thomas E. Emerson, Michael A. Fournel, et al. · The American Journal of Medicine · 95

Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine.

1992 · G Jesmok, C Lindsey, et al. · PubMed Central · 76

Inactivation of Human Antithrombin by Neutrophil Elastase

1989 · R E Jordan, R M Nelson, et al. · Journal of Biological Chemistry · 69

Prevention of Rhinovirus Infection in Chimpanzees by Soluble Intercellular Adhesion Molecule-1

1997 · E D Huguenel, D Cohn, et al. · American Journal of Respiratory and Critical Care Medicine · 64

Preparation and Properties of Alpha(1)-Proteinase Inhibitor Concentrate from Human Plasma

1985 · M.H. Coan, W.J. Brockway, et al. · Vox Sanguinis · 40

Clinical Safety, Tolerability, and Pharmacokinetics of Murine Monoclonal Antibody to Human Tumor Necrosis Factor-

1994 · L. D. Saravolatz, J. C. Wherry, et al. · The Journal of Infectious Diseases · 28

Preclinical review of anti-tumor necrosis factor monoclonal antibodies

1993 · MARK BODMER, MICHAEL A. FOURNEL, et al. · Critical Care Medicine · 25

Structural Study of the Sugar Chains of Porcine Factor VIII - Tissue- and Species-Specific Glycosylation of Factor VIII

1993 · T. Hironaka, K. Furukawa, et al. · Archives of Biochemistry and Biophysics · 22

Study of septic shock in the non-human primate: relationship of pathophysiological response to therapy with anti-TNF antibody.

1994 · L B Hinshaw, T E Emerson, et al. · PubMed · 21

Kinetics of activation of prekallikrein by prekallikrein activator

1980 · Donald L. Tankersley, Michael A. Fournel, et al. · Biochemistry · 20

IL-4 induced leucocyte trafficking in cynomolgus monkeys: correlation with expression of adhesion molecules and chemokine generation

1996 · R. GUNDEL, D. LINDELL, et al. · Clinical & Experimental Allergy · 19

Antithrombin inactivation by neutrophil elastase requires heparin

1989 · Robert E. Jordan, Richard M. Nelson, et al. · The American Journal of Medicine · 13

Preclinical evaluation of alpha-1-proteinase inhibitor

1988 · Michael A. Fournel, James O. Newgren, et al. · The American Journal of Medicine · 13

Plasma protein fraction

1981 · P. K. Ng, M. A. Fournel · Transfusion · 7

Properties of Commercial Factor Ix Concentrates

1981 · Michael H. Coan, Michael A. Fournel, et al. · Annals of the New York Academy of Sciences · 7

Site-specific Pegylation of Rfviii Results in Prolonged in Vivo Efficacy

2007 · J.E. Murphy, C. Pan, et al. · Journal of Thrombosis and Haemostasis · 4

Comparison of the survival of human factor VIII with and without von Willebrand factor in the hemophilic dog

1986 · Philip J. Fay, Charles Cavallaro, et al. · Thrombosis Research · 4

Towards a New Therapy for Hemophilia A: Evaluation of Multiple Approaches To Prolong the In Vivo Efficacy of Recombinant Factor VIII.

2006 · John E. Murphy, Clark Pan, et al. · Blood · 3

Bioethics From a Pragmatic Perspective: Ethical Issues in Biopharmaceuticals

2005 · Michael A Fournel · Acta bioethica · 3

PDF

Works count: 34

Citation count: 1,401

H-index: 17

I10-index: 19